Quarterly net loss of $9.5 million , EBITDA of $1.1 million , and Adjusted EBITDA of $4.4 million Reiterates Fiscal Year 2022 Guidance SANTA MARIA, Calif. , Sept. 29, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses,
SANTA MARIA, Calif. , Sept. 15, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc. , will hold a conference call on Wednesday, September 29, 2021 at 2 p.m.
Lifecore Biomedical Generates Full Year Revenue Growth of 14.3%, Net Income Growth of 23.1%, and Adjusted EBITDA Growth of 22.0% Curation Foods Achieves Fiscal Fourth Quarter Gross Margin of 11.9% on Revenue of $114.0 Million Landec Consolidated Full Year Revenues of $544.2 Million , Net Loss of
SANTA MARIA, Calif. , July 14, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc. , will hold a conference call on Wednesday, July 28, 2021 at 2 p.m.
Early sale to affiliates of founding and controlling investors for $45.1 million Net proceeds to be used to repay a portion of outstanding term debt and de-lever balance sheet SANTA MARIA, Calif. , June 01, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and
Lifecore Expands its Aseptic Production of Pharmaceutical Drugs CHASKA, Minn. , May 17, 2021 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. , a fully-owned subsidiary of Landec Corporation (Nasdaq: LNDC), today announced the receipt by Heron Therapeutics (“Heron”), one of Lifecore’s customers, of
A continuation of Project SWIFT, Agreement seeks to improve Curation Foods’ market reach while further simplifying operations, including facility rationalization SANTA MARIA, Calif. , May 05, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with
Lifecore Biomedical Generates Year-to-date Revenue Growth of 20%, Net Income Growth of 39%, and Adjusted EBITDA Growth of 34% Reiterates Fiscal 2021 Lifecore Biomedical Guidance Revises Curation Foods Fiscal 2021 Guidance to Reflect COVID-19 Headwinds SANTA MARIA, Calif.
SANTA MARIA, Calif. , March 23, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc. , will hold a conference call on Wednesday, April 7, 2021 at 2 p.m.
SANTA MARIA, Calif. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- It is with great sadness that the Landec Corporation (Nasdaq: LNDC) announces the death of board member Charles “Mac” Macaluso who passed away on February 22, 2021 . “Mac was an outstanding advisor and an integral member of our Board.